Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors

被引:29
|
作者
Soini, Y [1 ]
Paakko, P [1 ]
机构
[1] OULU UNIV HOSP, OULU, FINLAND
关键词
apoptosis; p53; bcl-2; germ cell tumor;
D O I
10.1016/S0046-8177(96)90318-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This study investigates the extent of apoptosis in 53 testicular and ovarian germ cell tumors by using the in situ 3'-end DNA labeling technique on tumor sections. The tumors were also immunostained with antibodies to the p53 and bcl-2 proteins. The extent of apoptosis was highest in embryonal carcinoma (mean, 2.9%) followed by seminoma (mean, 1.1%), choriocarcinoma (mean, 0.7%) and immature teratoma (mean, 0.7%). In individual components of the mixed germ cell tumors the apoptotic index was in the same range as in the corresponding pure germ cell tumors. Mature teratomas rarely contained any apoptotic cells. Sixty-two percent of all the tumors expressed p53 protein. p53 expression was quantitatively strongest in embryonal carcinomas which also showed the highest level of apoptosis. Bcl-2 positivity could only be detected in some mesenchymal and epithelial components of the immature and mature teratomas; embryonal carcinomas, seminomas, or choriocarcinomas did not express bcl-2 at all. Our results show that the level of apoptosis in germ cell tumors associates with the histological type of the neoplastic component independent of whether it is singly present or a component of a mixed germ cell tumor. The results suggest that the quantity of p53 expression may contribute to the level of apoptosis in different tumor groups. Copyright (C) 1996 by W.B. Saunders Company
引用
收藏
页码:1221 / 1226
页数:6
相关论文
共 50 条
  • [41] Expression of bcl-2 and p53 in Induction of Esophageal Cancer Cell Apoptosis by ECRG2 in Combination with Cisplatin
    Song, Hai-Yan
    Deng, Xiao-Hui
    Yuan, Guo-Yan
    Hou, Xin-Fang
    Zhu, Zhen-Dong
    Zhou, Li
    Ren, Ming-Xin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (03) : 1397 - 1401
  • [42] The p53–Bcl-2 connection
    M T Hemann
    S W Lowe
    Cell Death & Differentiation, 2006, 13 : 1256 - 1259
  • [43] COMPARATIVE EXPRESSION OF BCL-2 AND P53 IN ESTHESIONEUROBLASTOMAS AND RETINOBLASTOMAS
    MUNOZ, EL
    LOTANO, MA
    LEVINE, P
    LOPES, MBS
    GONZALEZFERNANDEZ, F
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (03): : 424 - 424
  • [44] Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas
    Bocaneti, Florentina
    Altamura, Gennaro
    Corteggio, Annunziata
    Velescu, Elena
    Borzacchiello, Giuseppe
    INFECTIOUS AGENTS AND CANCER, 2015, 10
  • [45] P53 AND BCL-2 PROTEIN EXPRESSION IN FOLLICULAR LYMPHOMAS
    NGUYEN, PL
    ZUKERBERG, LR
    HARRIS, NL
    LABORATORY INVESTIGATION, 1995, 72 (01) : A118 - A118
  • [46] Bax, Bcl-2, and p53 expression in endometrial cancer
    Sakuragi, N
    Salah-eldin, A
    Watari, H
    Itoh, T
    Inoue, S
    Moriuchi, T
    Fujimoto, S
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 288 - 296
  • [47] Expression of p53 and bcl-2 proteins in laryngeal cancer
    Gryczynski, M
    Kobos, J
    Pietruszewska, W
    4TH EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, VOLS 1 AND 2, 2000, : 731 - 735
  • [48] Expression of p53 and bcl-2 in adenomas and colorectal carcinoma
    Sundblad, AS
    Chumbita, RL
    Zoppi, JA
    MEDICINA-BUENOS AIRES, 1997, 57 (06) : 662 - 666
  • [49] p53 and bcl-2 expression in Barrett esophagus adenocarcinoma
    Soslow, RA
    Altorki, N
    LABORATORY INVESTIGATION, 1997, 76 (01) : 367 - 367
  • [50] bcl-2 and p53 oncoprotein expression in gastric adenocarcinomas
    Triantafyllou, K
    Kapranos, N
    Tzouvala, M
    Papatheodoridis, GV
    Zizi, A
    Elemenoglou, I
    Karamanolis, DG
    GUT, 1997, 41 : A143 - A144